10
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Turnover of 125I-labelled tissue kallikrein following intraduodenal or intravenous administration

Pages 57-67 | Published online: 08 Jul 2009

REFERENCES

  • Margolius HS. Tissue kallikreins structure, regul-ation and participation in mammalian physio-logy and disease. Clin Rev Allergy Immunol 1998; 16: 337–49.
  • Amouric M, Figarella C. Characterization and purification of a kallikrein from human pancreatic juice and immunological comparison with other kallikreins. Hoppe-Seyler's Z Physiol Chem 1979; 360: 457–65.
  • Tshesche H, Mair, Godec G, et al. The primary structure of poprcine glandular kallikreins. Inter-national symposium on kinins, Tokyo 1978. Adv Exp Med Biol 1979; 120A: 245–60.
  • Seidel G. Two functionally diffrent kininogens in human plasma. Agents Actions 1973; 3: 12–19.
  • Cohen WM, Wu H-F, Featherstone GL, Jenzano JW, Lundblad RL. Linkage between blood coagulation and inflammation: Stimulation of neutrofil tissue kallikrein by thrombin. Biochem and Biophys Res Comm 1991; 176: 315–20.
  • Christiansen SC, Proud D, Cochrane CG. Detec-tion of tissue kallikrein in the bronchoalvveolar lavage fluid of asthmatic subjects. J Clin Invest 1987; 79: 188–97.
  • Bläckberg M, Ohlsson K. Studies on the release of tissue kallikrein in experimental pancreatitis in the pig. Eur Surg Res 1994; 26: 116–24.
  • Bläckberg M, Berling R, Ohlsson K. Tissue kallikrein in severe acute pancreatitis in patients treated with high-dose intraperitoneal aprotinin. Pancreas 1999; 19: 325–34.
  • Chao J, Tillman DM, Wang M, Margolius HS, Chao L. Identification of a new tissue-kallikrein-binding protein. Biochem J 1986; 239: 325–31.
  • Bläckberg M, Ohlsson K. Interactions in vitro and in vivo between porcine tissue kallikrein and porcine plasma proteinase inhibitors. Scand J Clin Lab Invest 1994; 54: 643–51.
  • Geiger R, Stuckstede U, Clausnitzer B, Fritz H. Progressive inhibition of human glandular (urinary) kallikrein by human serum and identification of the progressive antikallikrein as alphal-antitrypsin (alphai-proteinase inhibitor). Hoppe-Seyler's Z Physiol Chem 1981; 362: 317–25.
  • Ecke S, Geiger M, Resch I, Jerabek I, Stingl L, Maier M, Binder BR. Inhibition of tissue kallik-rein by Protein C inhibitor. J Biol Chem 1992; 267: 7048–52.
  • Amundsen E, Putter J, Friberger P, Knos M, Larsbraten M, Claeson G. Methods for determi-nation of glandular kallikrein by means of chromogenic tripeptide substrate. Adv Exp Med Biol 1979; 120A: 83–95.
  • Fraker PJ, Speck JC Jr. Protein and cellmembrane iodinations with sparingly soluble chloramide 1,3,4,6-tetrachloro-3a,6a diphrenylglycoluril. Bio-chem Biophys Res Comm 1978; 80: 849–57.
  • Bacterial endotoxins test. In: The U.S. pharma-copeia, 23rd revision. Easton, PA: Mack Publish-ing Co, 1995: 1696–7.
  • Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227: 680–5.
  • Burnette WN. Western blotting: electrophoretic transfer of proteins from sodium dodecyl sulfate polyacrylamide gels to unmodified nitrocellulose and radiographic detection with antibody and radioiodinated protein A. Anal Biochem 1981; 112: 195–203.
  • Laurell CB. Electroimmunoassay. Scand J Clin Lab Invest 1972; 29(Suppl 124): 21–37.
  • Micic S, Tulic C, Dotlic R. Kallikrein therapy of infertile men with varicocele and impaired sperm motility. Andrologia 1990; 22: 179–83.
  • Bellini C, Carlomagno A, Piccoli A, Difrancesco L, Torregrossa G, Leonetti Luparini R, Germano G, Giarrizzo C, Ferri C, Santucci A, Balsano F. Efficacy and safety of oral kallikrein administra-tion in essential hypertensive patients. Ann Ital Med Int 1991; 6: 369–74.
  • Miska W, Schill W-B. Absorption study with porcine pancreatic kallikrein in man. Arzneimit-telforschung 1991; 41: 1061–4.
  • Fink E, Geiger R, Witte J, Biedermann S, Seifert J, Fritz H. Biochemical, pharmacological and functional aspects of glandular kallikreins. In: Gross F, Vogel G, eds. Enzymatic release of vasoactive peptides. New York: Raven Press, 1980: 101–15.
  • Roberts PR, Burney JD, Black KW, Zaloga GP. Effect of chain length on absorption of biolo-gically active peptides from the gastrointestinal tract. Digestion 1999; 60: 332–7.
  • Walker WA, Abel SN, Wu M, Bloch KJ. Intestinal uptake of macromolecules. V. Compar-ison of the in-vitro uptake by rat small intestine of antigen-antibody complexes prepared in antibody and antigen excess. J Immunol 1976; 117: 1028–32.
  • Sugimoto K, Ichikawa Y, Nakamura I. Absorp-tion of protein molecules by the small intestine of the bullfrog tadpole, Rana catesbeiana. J Exp Zool 1981; 215: 53–62.
  • Jones RE. De-iodination of labelled protein during intestinal transmission in the suckling rat. Proc R Soc 1977; 199: 279–90.
  • Kizuki K, Suzuki S, Aoki K, Kamada M, Ikekita M, Inaba T, Moriya H. Enzyme-linked immuno-sorbent assays for human tissue kallikrein and analysis of immunoreactive kallikrein in the plasma by them. Adv Exp Med Biol 1989; 247B: 211–6.
  • Borges DR, Sampio C, de la Llosa P, Prado JL. The liver is the main organ to clear plasma and tissue kallikreins from rat plasma, in vivo. Adv Exp Med Biol 1986; 198A: 229–33.
  • Kouyoumdjian M, Borges DR, Prado ES, Prado JL. Identification of receptors in the liver that mediate endocytosis of circulating tissue kallikreins. Biochim Biophys Acta 1989; 980: 299–304.
  • Aoki K, Kamada M, Ikekita M, Kizuki K, Moriya H. Tissue kallikrein clearance by the liver-effect of plasma components on kallikrein uptake by cultured rat hepatocytes. Agents Actions 1992; 38(Suppl): 157–64.
  • Xiong W, Tang CQ, Zhou GX, Chao L, Chao J. In vivo catabolism of human kallikrein-binding protein anhd its complex with tissue kallikrein. J Lab Clin Med 199 ; 119: 514–21.
  • Fink E, Schleuning M. Glomerular filtration of tissue kallikrein. Adv Exp Med Biol 1983; 156: 939–47.
  • Rabito SF, Seto M, Maitra SR, Carretero OA. Clearance and metabolism of glandular kallikrein in the rat. Am J Physiol 1985; 248: E664–8.
  • Nishimura K, Iwata T, Kokubu T. Plasma half-life and organ uptake ratio of radiolabeled glandular kallikrein in control and nephrectomized rats. Adv Exp Med Biol 1986; 198A: 309–13.
  • Fabris C, et al. Urinary kallikrein excretion in chronic pancreatic diseases. Am J Nephrol 1991; 11: 386–90.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.